| MeSH term | MeSH ID | Detail |
|---|---|---|
| Atherosclerosis | D050197 | 85 associated lipids |
| Respiratory Syncytial Virus Infections | D018357 | 10 associated lipids |
| Tibial Fractures | D013978 | 4 associated lipids |
| Thrombosis | D013927 | 49 associated lipids |
| Pulmonary Heart Disease | D011660 | 2 associated lipids |
| Pregnancy Complications | D011248 | 19 associated lipids |
| Liver Cirrhosis | D008103 | 67 associated lipids |
| Inflammation | D007249 | 119 associated lipids |
| Hypertension | D006973 | 115 associated lipids |
| Endometriosis | D004715 | 29 associated lipids |
2,3-dinor, 6-keto-PGF1alpha
2,3-dinor, 6-keto-pgf1alpha is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 782 references associated with 2,3-dinor, 6-keto-PGF1alpha in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 2,3-dinor, 6-keto-PGF1alpha
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 2,3-dinor, 6-keto-PGF1alpha
NCBI Entrez Crosslinks
All references with 2,3-dinor, 6-keto-PGF1alpha
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Reilly IA et al. | Increased thromboxane biosynthesis in a human preparation of platelet activation: biochemical and functional consequences of selective inhibition of thromboxane synthase. | 1986 | Circulation | pmid:2938849 |
| Roy L et al. | Endogenous biosynthesis of prostacyclin during cardiac catheterization and angiography in man. | 1985 | Circulation | pmid:3882264 |
| Wennmalm A et al. | Excretion of thromboxane A2 and prostacyclin metabolites during treadmill exercise in patients with intermittent claudication. | 1988 | Clin Physiol | pmid:3402185 |
| Wennmalm A | Formation of prostacyclin during administration of beta 1-selective and non-selective beta-adrenergic antagonists in healthy humans. | 1992 | Clin Physiol | pmid:1347260 |
| Wennmalm A et al. | Maintained hyperexcretion of thromboxane A2 metabolite in healthy young cigarette smokers: results from a prospective study in randomly sampled males with stable smoking habits. | 1993 | Clin Physiol | pmid:8519161 |
| Cibattoni G et al. | Effects of sulindac on renal and extrarenal eicosanoid synthesis. | 1987 | Clin. Pharmacol. Ther. | pmid:3549118 |
| Skarke C et al. | Comparative impact on prostanoid biosynthesis of celecoxib and the novel nonsteroidal anti-inflammatory drug CG100649. | 2012 | Clin. Pharmacol. Ther. | pmid:22278334 |
| Wennmalm A et al. | Non-invasive assessment of the cardiovascular eicosanoids, thromboxane A2 and prostacyclin, in randomly sampled males, with special reference to the influence of inheritance and environmental factors. | 1990 | Clin. Sci. | pmid:2176952 |
| Watson ML et al. | Urinary kallikrein and systemic prostacyclin synthesis during sodium chloride infusion in normal man. | 1985 | Clin. Sci. | pmid:3884237 |
| Förstermann U and Feuerstein TJ | Decreased systemic formation of prostaglandin E and prostacyclin, and unchanged thromboxane formation, in alcoholics during withdrawal as estimated from metabolites in urine. | 1987 | Clin. Sci. | pmid:3308287 |